Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
206.14
USD
+3.79 (+1.87%)
Official Closing Price
Updated: 7:58 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
7 Biotech Catalysts Remaining In January
January 13, 2017
Biotech stocks are regaining some lost momentum after Wednesday's Trump-inspired selloff that took a toll on the sentiment on pharma ...
Tags
Benzinga
Events
baricitinib
From
Benzinga
Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference
January 12, 2017
What should investors take away from the JPMorgan Healthcare Conference? Despite drug-pricing woes, sentiment is "cautiously optimistic."
Tags
Technology
From
Investor's Business Daily
Watch These 5 Huge Put Purchases In Friday Trade
January 12, 2017
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades ...
Tags
FCAU
Options
RESI
From
Benzinga
Investors in big pharma, biotech look to ride out Trump storm
January 12, 2017
NEW YORK, Jan 12 (Reuters) - Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new products to help ride out a storm of...
Tags
companyNews
From
Reuters: Company News
Pharma company executives debate drug pricing increases
January 12, 2017
SAN FRANCISCO Jan 12 (Reuters) - Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to limit annual increases to under 10 percent - but the...
Tags
companyNews
From
Reuters: Company News
Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva
January 12, 2017
Lilly stock bounded Thursday after a federal appellate court upheld the patent on chemo Alimta vs. drugmaker Teva.
Tags
Technology
From
Investor's Business Daily
Teva 'Disappointed' In Court's Patent Decision
January 12, 2017
In the latest development in the court battle between Eli Lilly And Co (NYSE: LLY) and Teva Pharmaceutical Industries Ltd (ADR) ...
Tags
Alimta
Benzinga
Legal
From
Benzinga
Teva loses appeal against Eli Lilly in Alimta patent case
January 12, 2017
Jan 12 (Reuters) - A U.S. appeals court on Thursday ruled in favor of Eli Lilly & Co in a closely-watched patent case, saying a lower court judge correctly found Teva Pharmaceutical Industries Ltd and...
Tags
companyNews
From
Reuters: Company News
BRIEF-U.S. appeals court rejects Teva appeal in Lilly patent case over Alimta
January 12, 2017
Jan 12 (Reuters) - U.S. Appeals Court rules for Eli Lilly and against Teva Pharmaceutical in Alimta patent case -- court ruling
Tags
companyNews
From
Reuters: Company News
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
January 11, 2017
Tags
LLY
NVS
PFE
From
Motley Fool
What pharma investors ought to do after Donald Trump fires a salvo
January 11, 2017
Reduce exposure to those industries on fears of a drug-price crackdown, says Nigam Arora.
Tags
JNJ
XBI
Medical Products
From
MarketWatch
BRIEF-Eli Lilly and Merck expand immuno-oncology collaboration
January 10, 2017
* Eli Lilly and co - financial details of collaboration were not disclosed.
Tags
companyNews
From
Reuters: Company News
Incyte's Prospects Get Even Brighter With Merck Announcement
January 09, 2017
Tags
INCY
MRK
LLY
From
Motley Fool
This Could Very Well Be the Greatest Drug Advancement in a Decade
January 09, 2017
Tags
BIIB
LLY
From
Motley Fool
Why Aratana Therapeutics Inc. Rocketed 42.7% Higher in 2016
January 09, 2017
Tags
PETX
LLY
From
Motley Fool
Five unpopular, but prudent, things for investors to do near Dow 20,000
January 09, 2017
It’s time to sell over-owned stocks and trim some others, says Nigam Arora.
Tags
MRK
Opinion
SPY
From
MarketWatch
The MedTech Group: 2017 Top Picks And Catalysts
January 06, 2017
Over the past year, the gap between MedTech stocks and the S&P index has narrowed significantly, and these are currently trading ...
Tags
ABMD
EXAS
ONVO
From
Benzinga
2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016
January 06, 2017
Tags
BMY
MRK
LLY
From
Motley Fool
BRIEF-Lilly to adjust organization and leadership structure to better align with growth opportunities
January 04, 2017
* Lilly to adjust organization and leadership structure to better align with growth opportunities
Tags
companyNews
From
Reuters: Company News
BRIEF-U.S. FDA approves supplemental New Drug Applications for three Type 2 diabetes medicines
January 04, 2017
* U.S. FDA approves supplemental new drug applications to include landmark data in product labels for synjardy (empagliflozin/metformin hydrochloride), synjardy xr (empagliflozin/metformin...
Tags
companyNews
From
Reuters: Company News
Lilly Nears FDA Nod On Arthritis Drug, But Chemo Med Stuck In Court
January 04, 2017
Drugmaker Eli Lilly will likely add a rheumatoid arthritis drug to its FDA-approved repertoire this month, Credit Suisse says.
Tags
Technology
From
Investor's Business Daily
My Worst Predictions for Biotech in 2016
January 03, 2017
Tags
XPH
VRX
PFE
From
Motley Fool
Two Key FDA Decisions To Watch Out For In January 2017
January 02, 2017
Several drug companies could see regulatory milestones passed in January 2017. Here's a look at a couple of important regulatory events scheduled for this month.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
Amgen Plans Robust 2017 In Alzheimer's, Migraines, Oncology: CEO Exclusive
January 02, 2017
Amgen expects to compete robustly in the anti-CGRP migraine market vs. Alder BioPharma, Teva Pharmaceutical and Eli Lilly.
Tags
Technology
From
Investor's Business Daily
In the age of Uber and Lyft, it’s still hard for some Americans to get to the doctor
December 29, 2016
When a researcher first started looking at high diabetes rates among Bangladeshi Americans, transportation was the heart of the problem.
Tags
Personal Finance
Retail
SPX
From
MarketWatch
Johnson & Johnson's 4 Biggest Catalysts in 2017
December 29, 2016
Tags
ABBV
LLY
JNJ
From
Motley Fool
UPDATE 1-U.S. FTC requires divestitures in $13.53 bln Boehringer-Sanofi deal
December 28, 2016
WASHINGTON, Dec 28 (Reuters) - German pharmaceutical company Boehringer Ingelheim agreed to divest five types of animal health products to settle charges that a proposed asset swap with Sanofi would...
Tags
companyNews
From
Reuters: Company News
A Preview Of January PDUFA Dates
December 28, 2016
Biopharma companies did not have much to write home about in the year 2016, as negative news flow on price gouging hit many stocks in ...
Tags
plecanatide
Biotech
VCEL
From
Benzinga
VTV, USB, LLY, LMT: ETF Inflow Alert
December 28, 2016
Symbols mentioned in this story: VTV, USB, LLY, LMT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Expect Availability Of Biogen's Newly Approved Spinraza In Just One Week
December 27, 2016
Biogen Inc (NASDAQ: BIIB) said its newly approved Spinraza (nusinersen) would be available in just one week time. Spinraza is approved ...
Tags
CLVS
FDA
Trading Ideas
From
Benzinga
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.